Covid Vax Scientists Scramble to Develop Bubonic Plague ‘Vaccine’ as ‘Next Pandemic’ Fears Grow

Bubonic plague fears as warning issued over antibiotic-resistant strains

The bubonic plague killed as many as 50 million people across Europe in the 14th century - 50% of its population - in what's known as the Black Death.

ThePatriotLight - Team Of Scientists Developing Bubonic Plague Vaccine * 100PercentFedUp.com * by Danielle

ThePatriotLight - The scientists who developed the Oxford/AstraZeneca COVID-19 jab are now making a bubonic plague vaccine. The Oxford team started a trial of its vaccine on 40 healthy adults in 2021. Prof Sir Andrew Pollard, director of the Oxford Vaccine Group, told The Telegraph the results of the trial will be submitted to a journal for peer review. They’re expected to conduct additional trials. 🚨Report: Oxford COVID-19 vaccine scientists a…

Black Death vaccine being developed over fears plague could reemerge

The Black Death killed as many as 50 million people during the 14th Century (Picture: Getty) Scientists who developed the AstraZeneca COVID jab are working on a new vaccine to combat the Black Death amid rising fears the plague could re-emerge. The plague first hit British shores in 1348 after being spread to Europe by fleas on rats aboard ships from Asia. Scientists estimate that between a third and a half of Britain’s population were killed b…

Covid Vaccine Scientists Creating New <br/>Shot for Bubonic Plague

Bubonic plague is a severe infectious and potentially fatal disease caused by the bacterium Yersinia pestis. It is the most common form of plague and is primari

Covid Vaccine Scientists Creating New Shot for Bubonic Plague

There are signs the plague bacteria has already developed resistance against antibiotics currently in use.

Team Of Scientists Developing Bubonic Plague Vaccine

The scientists who developed the Oxford/AstraZeneca COVID-19 jab are now making a bubonic plague vaccine. The Oxford team started a trial of its vaccine on 40 healthy adults in 2021. Prof Sir Andrew Pollard, director of the Oxford Vaccine Group, told The Telegraph the results of the trial will be submitted to a journal for peer review. They’re expected to conduct additional trials. Report: Oxford COVID-19 vaccine scientists are developing a bub…